Back to Journals » Therapeutics and Clinical Risk Management » Volume 18

Once-Daily Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults and Adolescents Aged 12 Years and Over: A Short Review of Current Clinical Perspectives

Total article views   HTML views PDF downloads Totals
5,867 Dovepress* 4,553+ 318 4,871
PubMed Central* 1,314 202 1,516
Totals 5,867 520 6,387
*Since 13 April 2022

View citations on PubMed Central and Google Scholar